160 related articles for article (PubMed ID: 28823810)
1. EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.
Thijs JL; Drylewicz J; Fiechter R; Strickland I; Sleeman MA; Herath A; May RD; Bruijnzeel-Koomen CAFM; Knol EF; Giovannone B; de Bruin-Weller MS; Nierkens S; Hijnen DJ
J Allergy Clin Immunol; 2017 Dec; 140(6):1703-1705. PubMed ID: 28823810
[No Abstract] [Full Text] [Related]
2. Significant correlation of serum IL-22 levels with CCL17 levels in atopic dermatitis.
Hayashida S; Uchi H; Takeuchi S; Esaki H; Moroi Y; Furue M
J Dermatol Sci; 2011 Jan; 61(1):78-9. PubMed ID: 21095106
[No Abstract] [Full Text] [Related]
3. Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis.
Kyoya M; Kawakami T; Soma Y
J Dermatol Sci; 2014 Sep; 75(3):204-7. PubMed ID: 24984931
[No Abstract] [Full Text] [Related]
4. [Biomarker of atopic dermatits -focusing on serum TARC/CCL17 level as severity marker-].
Saeki H
Arerugi; 2013 Feb; 62(2):131-7. PubMed ID: 23531648
[No Abstract] [Full Text] [Related]
5. The role of thymus and activation-regulated chemokine as a marker of severity of atopic dermatitis.
Himadri ; George R; Mathew L; Shanmugam V; Mani T; Jeyaseelan L
J Am Acad Dermatol; 2021 Feb; 84(2):545-547. PubMed ID: 32439469
[No Abstract] [Full Text] [Related]
6. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
[TBL] [Abstract][Full Text] [Related]
7. Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis.
Kimura T; Sugaya M; Suga H; Morimura S; Miyamoto A; Kai H; Kagami S; Yanaba K; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2014 May; 94(3):331-2. PubMed ID: 24104601
[No Abstract] [Full Text] [Related]
8. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
Bakker DS; Ariens LFM; Giovannone B; Hijnen D; Delemarre EM; Knol E; Nierkens S; de Bruin-Weller MS; Thijs JL; Drylewicz J
Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359
[No Abstract] [Full Text] [Related]
9. Chemokine levels in serum of children with atopic dermatitis with regard to severity and sensitization status.
Ahrens B; Schulz G; Bellach J; Niggemann B; Beyer K
Pediatr Allergy Immunol; 2015 Nov; 26(7):634-40. PubMed ID: 26102348
[TBL] [Abstract][Full Text] [Related]
10. Assessment and Clinical Relevance of Serum IL-19 Levels in Psoriasis and Atopic Dermatitis Using a Sensitive and Specific Novel Immunoassay.
Konrad RJ; Higgs RE; Rodgers GH; Ming W; Qian YW; Bivi N; Mack JK; Siegel RW; Nickoloff BJ
Sci Rep; 2019 Mar; 9(1):5211. PubMed ID: 30914699
[TBL] [Abstract][Full Text] [Related]
11. Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity.
Landheer J; de Bruin-Weller M; Boonacker C; Hijnen D; Bruijnzeel-Koomen C; Röckmann H
J Am Acad Dermatol; 2014 Dec; 71(6):1160-6. PubMed ID: 25199679
[TBL] [Abstract][Full Text] [Related]
12. The Self-administered Eczema Area and Severity Index in children with moderate to severe atopic dermatitis: better estimation of AD body surface area than severity.
van Velsen SG; Knol MJ; Haeck IM; Bruijnzeel-Koomen CA; Pasmans SG
Pediatr Dermatol; 2010; 27(5):470-5. PubMed ID: 20796235
[TBL] [Abstract][Full Text] [Related]
13. Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of immunoglobulin E and thymus and activation-regulated chemokine but not clinical severity in a real-world setting.
Uchida H; Kamata M; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Am Acad Dermatol; 2020 May; 82(5):1247-1249. PubMed ID: 31884090
[No Abstract] [Full Text] [Related]
14. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.
Kwakkel-van Erp JM; Haeck IM; Paantjens AW; van de Graaf EA; van Ginkel WG; Knol MJ; de Bruin-Weller MS; Lammers JW; Knol EF; Bruijnzeel-Koomen C; Otten HG
J Am Acad Dermatol; 2010 Sep; 63(3):e70-2. PubMed ID: 20708466
[No Abstract] [Full Text] [Related]
15. Serum Thymus and Activation Regulated Chemokine (TARC), IL- 18 and IL-18 Gene Polymorphism as Associative Factors with Atopic Dermatitis.
Gohar MK; Atta AH; Nasr MM; Hussein DN
Egypt J Immunol; 2017 Jun; 24(2):9-22. PubMed ID: 29528575
[TBL] [Abstract][Full Text] [Related]
16. Case of atopic dermatitis concurrent with idiopathic thrombocytopenic purpura, whose serum thymus and activation-regulated chemokine level remained undetectable.
Ozawa M; Sasahara Y; Aiba S
J Dermatol; 2018 May; 45(5):606-608. PubMed ID: 29399856
[TBL] [Abstract][Full Text] [Related]
17. Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis.
Hayashida S; Uchi H; Moroi Y; Furue M
J Dermatol Sci; 2011 Mar; 61(3):180-6. PubMed ID: 21255981
[TBL] [Abstract][Full Text] [Related]
18. Reduction of serum thymus and activation-regulated chemokine after short-term intensive therapy may predict better prognosis of moderate to severe atopic dermatitis.
Saito R; Tanaka A; Hiragun T; Iwamoto K; Takahagi S; Takahashi M; Hide M
J Dermatol; 2019 Dec; 46(12):e486-e487. PubMed ID: 31376173
[No Abstract] [Full Text] [Related]
19. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2002 Feb; 127(2):270-3. PubMed ID: 11876749
[TBL] [Abstract][Full Text] [Related]
20. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
